annual accounts payable:
$16.59M+$1.80M(+12.15%)Summary
- As of today (July 1, 2025), CPRX annual accounts payable is $16.59 million, with the most recent change of +$1.80 million (+12.15%) on December 31, 2024.
- During the last 3 years, CPRX annual accounts payable has risen by +$13.82 million (+499.46%).
- CPRX annual accounts payable is now at all-time high.
Performance
CPRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$11.20M-$5.40M(-32.52%)Summary
- As of today (July 1, 2025), CPRX quarterly accounts payable is $11.20 million, with the most recent change of -$5.40 million (-32.52%) on March 31, 2025.
- Over the past year, CPRX quarterly accounts payable has increased by +$936.00 thousand (+9.12%).
- CPRX quarterly accounts payable is now -32.52% below its all-time high of $16.59 million, reached on December 31, 2024.
Performance
CPRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CPRX Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +12.2% | +9.1% |
3 y3 years | +499.5% | +117.9% |
5 y5 years | +303.0% | +730.9% |
CPRX Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +499.5% | -32.5% | +383.7% |
5 y | 5-year | at high | +499.5% | -32.5% | +458.4% |
alltime | all time | at high | >+9999.0% | -32.5% | >+9999.0% |
CPRX Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $11.20M(-32.5%) |
Dec 2024 | $16.59M(+12.2%) | $16.59M(+43.5%) |
Sep 2024 | - | $11.56M(+62.5%) |
Jun 2024 | - | $7.12M(-30.7%) |
Mar 2024 | - | $10.26M(-30.6%) |
Dec 2023 | $14.79M(+272.2%) | $14.79M(+221.8%) |
Sep 2023 | - | $4.60M(+4.0%) |
Jun 2023 | - | $4.42M(+30.4%) |
Mar 2023 | - | $3.39M(-14.7%) |
Dec 2022 | $3.98M(+43.6%) | $3.98M(+57.2%) |
Sep 2022 | - | $2.53M(+9.2%) |
Jun 2022 | - | $2.31M(-55.0%) |
Mar 2022 | - | $5.14M(+85.7%) |
Dec 2021 | $2.77M(-35.0%) | $2.77M(+0.6%) |
Sep 2021 | - | $2.75M(-5.9%) |
Jun 2021 | - | $2.92M(+14.2%) |
Mar 2021 | - | $2.56M(-39.8%) |
Dec 2020 | $4.26M(+3.4%) | $4.26M(+112.2%) |
Sep 2020 | - | $2.01M(-65.5%) |
Jun 2020 | - | $5.80M(+330.8%) |
Mar 2020 | - | $1.35M(-67.3%) |
Dec 2019 | $4.12M(+76.2%) | $4.12M(-0.7%) |
Sep 2019 | - | $4.15M(+24.6%) |
Jun 2019 | - | $3.33M(+13.2%) |
Mar 2019 | - | $2.94M(+25.8%) |
Dec 2018 | $2.34M(+20.1%) | $2.34M(+74.3%) |
Sep 2018 | - | $1.34M(+45.4%) |
Jun 2018 | - | $922.60K(+14.6%) |
Mar 2018 | - | $805.00K(-58.6%) |
Dec 2017 | $1.95M(+108.5%) | $1.95M(+79.9%) |
Sep 2017 | - | $1.08M(+56.2%) |
Jun 2017 | - | $692.30K(-24.6%) |
Mar 2017 | - | $917.90K(-1.6%) |
Dec 2016 | $933.20K(-48.0%) | $933.20K(-11.6%) |
Sep 2016 | - | $1.06M(+49.2%) |
Jun 2016 | - | $707.30K(-43.5%) |
Mar 2016 | - | $1.25M(-30.2%) |
Dec 2015 | $1.79M | $1.79M(+119.6%) |
Sep 2015 | - | $817.00K(-37.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $1.32M(+25.3%) |
Mar 2015 | - | $1.05M(-42.1%) |
Dec 2014 | $1.81M(+113.2%) | $1.81M(+245.7%) |
Sep 2014 | - | $524.80K(-57.6%) |
Jun 2014 | - | $1.24M(+32.8%) |
Mar 2014 | - | $932.10K(+9.6%) |
Dec 2013 | $850.80K(-37.7%) | $850.80K(-42.3%) |
Sep 2013 | - | $1.47M(+228.6%) |
Jun 2013 | - | $448.30K(-21.0%) |
Mar 2013 | - | $567.20K(-58.5%) |
Dec 2012 | $1.37M(+417.5%) | $1.37M(+283.7%) |
Sep 2012 | - | $355.90K(+59.6%) |
Jun 2012 | - | $223.00K(-36.3%) |
Mar 2012 | - | $350.30K(+32.7%) |
Dec 2011 | $263.90K(+149.2%) | $263.90K(+51.7%) |
Sep 2011 | - | $174.00K(-63.6%) |
Jun 2011 | - | $478.00K(+12.4%) |
Mar 2011 | - | $425.40K(+301.7%) |
Dec 2010 | $105.90K(-57.6%) | $105.90K(-56.1%) |
Sep 2010 | - | $241.30K(-4.2%) |
Jun 2010 | - | $252.00K(+185.4%) |
Mar 2010 | - | $88.30K(-64.6%) |
Dec 2009 | $249.60K(-25.0%) | $249.60K(+53.0%) |
Sep 2009 | - | $163.10K(-40.8%) |
Jun 2009 | - | $275.70K(-62.6%) |
Mar 2009 | - | $737.60K(+121.7%) |
Dec 2008 | $332.70K(+51.3%) | $332.70K(-47.7%) |
Sep 2008 | - | $635.60K(+250.6%) |
Jun 2008 | - | $181.30K(-42.7%) |
Mar 2008 | - | $316.60K(+44.0%) |
Dec 2007 | $219.90K(-50.9%) | $219.90K(-4.2%) |
Sep 2007 | - | $229.50K(+56.8%) |
Jun 2007 | - | $146.40K(-53.2%) |
Mar 2007 | - | $312.50K(-30.3%) |
Dec 2006 | $448.10K(+560.9%) | $448.10K(+7.3%) |
Sep 2006 | - | $417.80K(+1577.9%) |
Jun 2006 | - | $24.90K(-63.3%) |
Dec 2005 | $67.80K(+120.8%) | $67.80K(+120.8%) |
Dec 2004 | $30.70K | $30.70K |
FAQ
- What is Catalyst Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual accounts payable year-on-year change?
- What is Catalyst Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly accounts payable year-on-year change?
What is Catalyst Pharmaceuticals annual accounts payable?
The current annual accounts payable of CPRX is $16.59M
What is the all time high annual accounts payable for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual accounts payable is $16.59M
What is Catalyst Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CPRX annual accounts payable has changed by +$1.80M (+12.15%)
What is Catalyst Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CPRX is $11.20M
What is the all time high quarterly accounts payable for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly accounts payable is $16.59M
What is Catalyst Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CPRX quarterly accounts payable has changed by +$936.00K (+9.12%)